meglumine has been researched along with Bile Duct Cancer in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 4 (22.22) | 29.6817 |
| 2010's | 10 (55.56) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Chen, X; Huang, H; Lin, X; She, D; Xiong, M; Zheng, W | 1 |
| Agarwal, S; Brunt, EM; Fowler, KJ; Menias, CO; Narra, VR; Shetty, AS | 1 |
| Koh, DM; Riddell, AM; Thian, YL | 1 |
| Al Ansari, N; Altun, E; Calvo, B; Kim, BS; Ramalho, M; Semelka, CT; Semelka, RC; Srirattanapong, S; Woosley, JT | 1 |
| Byun, JH; Hong, N; Hong, SM; Kim, HJ; Kim, JH; Kim, KW; Kim, SY | 1 |
| Carollo, V; Caruso, S; Crino', F; Gentile, G; Luca, A; Mamone, G; Marrone, G; Milazzo, M | 1 |
| Bolondi, L; Colombo, M; Forzenigo, LV; Galassi, M; Golfieri, R; Granito, A; Iavarone, M; Piscaglia, F; Renzulli, M; Salvatore, V; Sangiovanni, A; Vavassori, S | 1 |
| Choi, BI; Han, JK; Kim, KW; Kim, SH; Lee, DH; Lee, JM; Lee, JY; Park, HS | 1 |
| Jeon, TY; Kim, SH; Lee, WJ; Lim, HK | 1 |
| Czarnecka, A; Lüdemann, L; Mohnike, K; Pech, M; Ricke, J; Rühl, R; Seidensticker, M; Streitparth, F; Wust, P | 1 |
| Baek, JH; Choi, BI; Han, JK; Kim, JE; Kim, SH; Lee, JM; Lee, JY; Moon, SK; Yu, IS | 1 |
| Alexander Grant, L; Burke, C; Goh, V; Griffin, N | 1 |
| Cha, SW; Kim, KW; Lee, DK; Park, MS; Yoon, DS; Yu, JS | 1 |
| Fries, P; Pistorius, G; Schneider, G; Seidel, R; Weinrich, M | 1 |
| Gualdi, G; Manfredi, R; Masselli, G; Vecchioli, A | 1 |
| Guthrie, JA; Robinson, PJ; Ward, J | 1 |
| Grazioli, L; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
| Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Murakami, T; Ohtomo, K; Tanaka, Y; Tanimoto, A; Yoshikawa, K | 1 |
2 review(s) available for meglumine and Bile Duct Cancer
| Article | Year |
|---|---|
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2013 |
The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
Topics: Bile Duct Neoplasms; Bile Ducts; Contrast Media; Edetic Acid; Gadolinium DTPA; Hepatocytes; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Pyridoxal Phosphate | 2013 |
2 trial(s) available for meglumine and Bile Duct Cancer
| Article | Year |
|---|---|
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Topics: Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies | 1999 |
Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver tumors in Japan.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Japan; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Safety | 1999 |
14 other study(ies) available for meglumine and Bile Duct Cancer
| Article | Year |
|---|---|
Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2022 |
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phenotype; Risk Factors; Tomography, X-Ray Computed | 2014 |
Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI?
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Reproducibility of Results | 2014 |
Neuroendocrine neoplasms of the extrahepatic bile duct: radiologic and clinical characteristics.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Contrast Media; Female; Humans; Image Enhancement; Iohexol; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Positron-Emission Tomography; Retrospective Studies; Tomography, X-Ray Computed | 2015 |
Intrahepatic mass-forming cholangiocarcinoma: enhancement pattern on Gd-BOPTA-MRI with emphasis of hepatobiliary phase.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts; Cholangiocarcinoma; Contrast Media; Female; Humans; Image Enhancement; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2015 |
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Hepatocytes; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2015 |
MR imaging findings of early bile duct cancer.
Topics: Aged; Bile Duct Neoplasms; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2008 |
The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2010 |
Radiobiological restrictions and tolerance doses of repeated single-fraction hdr-irradiation of intersecting small liver volumes for recurrent hepatic metastases.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Brachytherapy; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Follow-Up Studies; Hepatocytes; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Recurrence, Local; Organometallic Compounds; Radiation Tolerance; Radiotherapy Dosage; Survival Rate; Treatment Outcome | 2010 |
Differentiation of intraductal growing-type cholangiocarcinomas from nodular-type cholangiocarcinomas at biliary MR imaging with MR cholangiography.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Chi-Square Distribution; Cholangiocarcinoma; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Diagnosis, Differential; Female; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2010 |
Gadobenate dimeglumine-enhanced MRI of intraductal papillary mucinous tumor of the bile ducts.
Topics: Bile Duct Neoplasms; Carcinoma, Papillary; Cholangiography; Cholangiopancreatography, Endoscopic Retrograde; Contrast Media; Cystadenoma, Mucinous; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Rare Diseases; Tomography, X-Ray Computed | 2007 |
Biliary cystadenoma of the left intrahepatic duct (2007: 2b).
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Contrast Media; Cystadenoma; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2007 |
MR imaging and MR cholangiopancreatography in the preoperative evaluation of hilar cholangiocarcinoma: correlation with surgical and pathologic findings.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Humans; Male; Meglumine; Middle Aged; Organometallic Compounds; Preoperative Care; Reproducibility of Results; Sensitivity and Specificity | 2008 |
Hilar cholangiocarcinomas: T2-weighted spin-echo and gadolinium-enhanced FLASH MR imaging.
Topics: Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Hepatic Duct, Common; Humans; Klatskin Tumor; Liver; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1996 |